Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Neuroscience

Items 31-39 of 39

Page
per page
  1. Anti-DLL4 Antibody (Demcizumab)
    F1542 Anti-DLL4 Antibody (Demcizumab)
    Summary: Anti-DLL4 Antibody (Demcizumab)
  2. Anti-DLL4 Antibody (Enoticumab)
    F1543 Anti-DLL4 Antibody (Enoticumab)
    Summary: Anti-DLL4 Antibody (Enoticumab)
  3. Anti-Alpha-synuclein Antibody (Prasinezumab)
    F1544 Anti-Alpha-synuclein Antibody (Prasinezumab)
    Summary: Anti-Alpha-synuclein Antibody (Prasinezumab)
  4. Anti-DLL3 Antibody (Rovalpituzumab)
    F1545 Anti-DLL3 Antibody (Rovalpituzumab)
    Summary: Anti-DLL3 Antibody (Rovalpituzumab)
  5. Anti-Tau Antibody (Bepranemab)
    F1546 Anti-Tau Antibody (Bepranemab)
    Summary: Anti-Tau Antibody (Bepranemab)
  6. Anti-Tau Antibody (Tilavonemab)
    F1547 Anti-Tau Antibody (Tilavonemab)
    Summary: Anti-Tau Antibody (Tilavonemab)
  7. Anti-NOTCH1 Antibody (Brontictuzumab)
    F1548 Anti-NOTCH1 Antibody (Brontictuzumab)
    Summary: Anti-NOTCH1 Antibody (Brontictuzumab)
  8. Phenelzine sulfate
    A9913 Phenelzine sulfate
    Summary: A monoamine oxidase inhibitor
      ≥38.6 mg/mL
  9. Ethyl 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate
    A9976 Ethyl 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate
    Summary: A potent selective inhibitor of human monoamine oxidase B (hMAO-B)
      ≥49.3 mg/mL

Items 31-39 of 39

Page
per page